A comparative synchronous coronary surgery survival study

Area of Science:

• Cardiovascular Surgery
• Clinical Outcomes Research
• Epidemiology

Background:

• The Veterans Administration Cooperative (VAC) Study established criteria for evaluating surgical versus medical treatment for coronary artery disease.
• Comparing long-term survival is crucial for determining optimal treatment strategies.

Purpose of the Study:

• To compare the 4-year survival rates of surgically treated patients with those of medically treated patients.
• To analyze survival outcomes based on the extent of coronary artery disease and left ventricular function.

Main Methods:

• A retrospective analysis of 229 surgically treated patients (1972-1974) using VAC Study criteria.
• Comparison with a cohort of 310 medically treated patients from the VAC Study.
• Inclusion of operative mortality in surgical group survival rates.

Main Results:

• Surgical therapy demonstrated a 95% to 85% cumulative 4-year survival advantage over medical treatment.
• Patients with three-vessel disease showed significantly better survival with surgery (94%) versus medical treatment (80%).
• Improved survival for surgical intervention was also noted in two-vessel disease patients, especially with abnormal left ventricles (93% vs. 84%).

Conclusions:

• Surgical intervention provides a significant 4-year survival benefit for patients with coronary artery disease, particularly those with multi-vessel involvement.
• The survival advantage of surgery is most pronounced in patients with three-vessel disease and those with two-vessel disease and impaired left ventricular function.
• No significant survival difference was observed between surgical and medical cohorts for patients with single-vessel disease.